Search

Home > New FDA Approvals > 054 - FDA approves Giapreza (angiotensin II) injection to treat dangerously low blood pressure; FDA approves Macrilen for adult growth hormone deficiency diagnosis; New drug approvals for FDA: 2017 matches all-time high
Podcast: New FDA Approvals
Episode:

054 - FDA approves Giapreza (angiotensin II) injection to treat dangerously low blood pressure; FDA approves Macrilen for adult growth hormone deficiency diagnosis; New drug approvals for FDA: 2017 matches all-time high
Category: Science & Medicine
Duration: 00:09:06
Publish Date: 2017-12-22 07:00:00
Description:

December 22, 2017

0:45 - FDA approves Giapreza (angiotensin II) injection to treat dangerously low blood pressure

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm590249.htm

http://ir.lajollapharmaceutical.com/phoenix.zhtml?c=102516&p=irol-newsArticle&ID=2323899

2:12 - FDA approves Macrilen for adult growth hormone deficiency diagnosis http://ir.aezsinc.com/press-release/aeterna-zentaris-announces-fda-approval-macrilen-macimorelin-diagnosis-adult-growth

4:21 - New drug approvals for FDA: 2017 matches all-time high

http://www.raps.org/Regulatory-Focus/News/2017/12/21/29099/New-Drug-Approvals-for-FDA-2017-Matches-All-Time-High/

Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. contact info@nascentmc.com

 
Total Play: 0